MINDY HOUPT: Open Payments
NPI 1497128409 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 38 payments from 12 companies in 2025. Trend: 2023 $134 · 2024 $677 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $150 |
| Novo Nordisk Inc | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 4 | $61 |
| PFIZER INC. | 2 | $47 |
| Exact Sciences Corporation | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Dexcom, Inc. | 1 | $25 |
Products named: Wegovy, VRAYLAR, Kerendia, MOUNJARO, QULIPTA, UBRELVY, AIRSUPRA, EVENITY.
Industry payments across MI — which companies pay providers there.
